EICHOR
● Active Not Recruiting
A Study to Evaluate the Safety and Efficacy of CD388 for Prevention of Influenza
Condition: Influenza · Sponsor: Cidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
About this study
The purpose of this study is to evaluate how well CD388 works in preventing symptomatic laboratory-confirmed influenza infections, as compared to placebo, when given as a single dose via 3 subcutaneous (SQ) injections to adult and adolescent participants who are at higher risk of developing influenza complications, and to evaluate the safety and tolerability of CD388, as compared to placebo.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (181)
| Pinnacle Research Group, LLC | Anniston, Alabama, United States | — |
| Cullman Clinical Trials | Cullman, Alabama, United States | — |
| HOPE Research Institute | Glendale, Arizona, United States | — |
| Desert Clinical Research, LLC / Avacare | Mesa, Arizona, United States | — |
| Foothills Research Center / Avacare | Phoenix, Arizona, United States | — |
| Fiel Family and Sports Medicine / Avacare | Tempe, Arizona, United States | — |
| HOPE Research Institute | Tempe, Arizona, United States | — |
| Arizona Clinical Trials | Tucson, Arizona, United States | — |
| Del Sol Research Management, LLC | Tucson, Arizona, United States | — |
| Triallogix Medical Corporation | Fullerton, California, United States | — |
| National Institute of Clinical Research, Inc. | Garden Grove, California, United States | — |
| Eximia Research-CA, LLC | La Mesa, California, United States | — |
+ 169 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07159763